{
    "Trade/Device Name(s)": [
        "QUANTA Flash\u00ae Scl-70",
        "QUANTA Flash\u00ae Scl-70 Calibrators",
        "QUANTA Flash\u00ae Scl-70 Controls"
    ],
    "Submitter Information": "Inova Diagnostics, Inc.",
    "510(k) Number": "K152635",
    "Predicate Device Reference 510(k) Number(s)": [
        "K924898"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LLL",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "April 27, 2016",
    "Summary Letter Received Date": "April 29, 2016",
    "Submission Date": "August 28, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.5100",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Antinuclear Antibodies Immunological Test System",
        "Calibrator",
        "Single (specified) analyte controls (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG anti-Scl-70 autoantibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BIO-FLASH\u00ae instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Solid phase (heterogeneous) immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for QUANTA Flash Scl-70 chemiluminescent immunoassay and associated calibrators and controls for detection of IgG anti-Scl-70 autoantibodies to aid in diagnosis of systemic sclerosis",
    "Indications for Use Summary": "Semi-quantitative determination of IgG anti-Scl-70 autoantibodies in human serum to aid in the diagnosis of systemic sclerosis, with calibrators for assay reference and controls for quality control, used on the BIO-FLASH instrument.",
    "fda_folder": "Immunology"
}